Haematologica (Jun 2022)

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia

Naseema Gangat,
Jonathan Bleeker,
Douglas Lynch,
Horatiu Olteanu,
Louis Letendre,
Ayalew Tefferi

Affiliations

Naseema Gangat: Division of Hematology, Mayo Clinic, Rochester, MN
Jonathan Bleeker: Division of Hematology and Hematopathology, Sanford Health, Sioux Falls, SD
Douglas Lynch: Division of Hematology and Hematopathology, Sanford Health, Sioux Falls, SD
Horatiu Olteanu: Division of Hematopathology, Mayo Clinic, Rochester, MN
Louis Letendre: Division of Hematology, Mayo Clinic, Rochester, MN
Ayalew Tefferi: Division of Hematology, Mayo Clinic, Rochester, MN

DOI: https://doi.org/10.3324/haematol.2022.281398
Journal volume & issue: Vol. 107, no. 10

Abstract

No abstracts available.

Published in Haematologica

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org

About the journal